Castillo JJ - Search Results

1

Cellular immunotherapy for refractory hematological malignancies.

Reagan JL, Fast LD, Safran H, Nevola M, Winer ES, Castillo JJ, Butera JN, Quesenberry MI, Young CT, Quesenberry PJ. Reagan JL, et al. Among authors: castillo jj. J Transl Med. 2013 Jun 19;11:150. doi: 10.1186/1479-5876-11-150. J Transl Med. 2013. PMID: 23782682 Free PMC article. Clinical Trial.

2

Newer monoclonal antibodies for hematological malignancies.

Castillo J, Winer E, Quesenberry P. Castillo J, et al. Exp Hematol. 2008 Jul;36(7):755-68. doi: 10.1016/j.exphem.2008.04.018. Exp Hematol. 2008. PMID: 18565392 Free article. Review.

3

Are we training our fellows adequately in delivering bad news to patients? A survey of hematology/oncology program directors.

Hebert HD, Butera JN, Castillo J, Mega AE. Hebert HD, et al. J Palliat Med. 2009 Dec;12(12):1119-24. doi: 10.1089/jpm.2009.0074. J Palliat Med. 2009. PMID: 19698025

4

Management of hematological malignancies during pregnancy.

Rizack T, Mega A, Legare R, Castillo J. Rizack T, et al. Am J Hematol. 2009 Dec;84(12):830-41. doi: 10.1002/ajh.21547. Am J Hematol. 2009. PMID: 19844988 Free article. Review.

5

Prognostic factors in chemotherapy-treated patients with HIV-associated Plasmablastic lymphoma.

Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, Colvin G, Butera JN. Castillo JJ, et al. Oncologist. 2010;15(3):293-9. doi: 10.1634/theoncologist.2009-0304. Epub 2010 Feb 18. Oncologist. 2010. PMID: 20167839 Free PMC article.

6

Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma.

Castillo JJ, Winer ES, Stachurski D, Perez K, Jabbour M, Milani C, Colvin G, Butera JN. Castillo JJ, et al. Leuk Lymphoma. 2010 Nov;51(11):2047-53. doi: 10.3109/10428194.2010.516040. Epub 2010 Oct 4. Leuk Lymphoma. 2010. PMID: 20919850

7

Complete remission in two cases of adult T-cell leukemia/lymphoma treated with hyper-CVAD: a case report and review of the literature.

Alduaij A, Butera JN, Treaba D, Castillo J. Alduaij A, et al. Clin Lymphoma Myeloma Leuk. 2010 Dec;10(6):480-3. doi: 10.3816/CLML.2010.n.084. Clin Lymphoma Myeloma Leuk. 2010. PMID: 21156467 Review.

8

Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far.

Castillo JJ, Beltran BE, Miranda RN, Paydas S, Winer ES, Butera JN. Castillo JJ, et al. Oncologist. 2011;16(1):87-96. doi: 10.1634/theoncologist.2010-0213. Epub 2011 Jan 6. Oncologist. 2011. PMID: 21212426 Free PMC article. Review.

9

Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia.

Reagan JL, Castillo JJ. Reagan JL, et al. Among authors: castillo jj. Expert Rev Anticancer Ther. 2011 Feb;11(2):151-60. doi: 10.1586/era.10.223. Expert Rev Anticancer Ther. 2011. PMID: 21342032 Review.

10

Plasmablastic lymphoma: a systematic review.

Castillo JJ, Reagan JL. Castillo JJ, et al. ScientificWorldJournal. 2011 Mar 22;11:687-96. doi: 10.1100/tsw.2011.59. ScientificWorldJournal. 2011. PMID: 21442146 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

372 results

Search Page